Not Medicare Enrolled

Amie Gimon, ARNP

Gerontology Nurse Practitioner · Altamonte Springs, FL
405 W CENTRAL PKWY, Altamonte Springs, FL 32714
4077904990
Registered in NPPES since 2017
NPI: 1881135598 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Gimon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Gimon? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Gimon

Amie Gimon is a gerontology nurse practitioner in Altamonte Springs, FL, with 9 years of NPI registration.

Between the years covered by Open Payments, Gimon received a total of $16,558 from 65 pharmaceutical and/or device companies across 657 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Gimon is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years of NPI registration $16,558 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$16,558
Total received (2021-2024)
Avg $4,139/year across 4 years
Top 1% in FL for gerontology nurse practitioner
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
657
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,137
2023
$4,015
2022
$3,706
2021
$4,700

Payments by company (2024)

ABBVIE INC.
$793
Neurocrine Biosciences, Inc.
$455
Lilly USA, LLC
$294
Eisai Inc.
$259
Biogen, Inc.
$258
UCB, Inc.
$189
Medtronic, Inc.
$158
Lundbeck LLC
$153
ARGENX US, INC.
$152
CATALYST PHARMACEUTICALS, INC.
$130
Alexion Pharmaceuticals, Inc.
$109
PFIZER INC.
$101
Teva Pharmaceuticals USA, Inc.
$96
Novartis Pharmaceuticals Corporation
$83
Takeda Pharmaceuticals U.S.A., Inc.
$77
MITSUBISHI TANABE PHARMA AMERICA, INC.
$75
Amgen Inc.
$71
SCILEX PHARMACEUTICALS INC.
$69
CSL Behring
$62
EMD Serono, Inc.
$62
Alnylam Pharmaceuticals Inc.
$60
Sumitomo Pharma America, Inc.
$58
GENZYME CORPORATION
$57
Otsuka America Pharmaceutical, Inc.
$50
Neurelis, Inc.
$42
GE HEALTHCARE
$41
JAZZ PHARMACEUTICALS INC.
$33
SK Life Science, Inc.
$32
Grifols USA, LLC
$22
Genentech USA, Inc.
$22
Vanda Pharmaceuticals Inc.
$21
LivaNova USA, Inc.
$20
Amneal Pharmaceuticals LLC
$17
Kyowa Kirin, Inc.
$15
Top 3 companies account for 37.3% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$1,573
Biogen, Inc.
$1,438
Neurocrine Biosciences, Inc.
$1,397
GENZYME CORPORATION
$872
Alexion Pharmaceuticals, Inc.
$863
EMD Serono, Inc.
$755
Lilly USA, LLC
$674
Teva Pharmaceuticals USA, Inc.
$568
Celgene Corporation
$530
Genentech USA, Inc.
$487
Eisai Inc.
$457
UCB, Inc.
$412
AbbVie Inc.
$403
Alnylam Pharmaceuticals Inc.
$349
Novartis Pharmaceuticals Corporation
$341
ARGENX US, INC.
$324
Biohaven Pharmaceuticals, Inc.
$321
Lundbeck LLC
$314
TG THERAPEUTICS, INC.
$307
JAZZ PHARMACEUTICALS INC.
$214
Horizon Therapeutics plc
$209
SK Life Science, Inc.
$206
PFIZER INC.
$196
Amneal Pharmaceuticals LLC
$193
CSL Behring
$177
Mallinckrodt Hospital Products Inc.
$171
Janssen Pharmaceuticals, Inc
$164
MITSUBISHI TANABE PHARMA AMERICA, INC.
$161
Amgen Inc.
$158
Supernus Pharmaceuticals, Inc.
$158
Medtronic, Inc.
$158
Takeda Pharmaceuticals U.S.A., Inc.
$133
Biohaven Pharmaceutical Holding Company Ltd.
$131
CATALYST PHARMACEUTICALS, INC.
$130
E.R. Squibb & Sons, L.L.C.
$128
Abbott Laboratories
$125
Grifols USA, LLC
$118
ACADIA Pharmaceuticals Inc
$106
Sunovion Pharmaceuticals Inc.
$105
Otsuka America Pharmaceutical, Inc.
$104
Sumitomo Pharma America, Inc.
$97
UPSHER-SMITH LABORATORIES LLC
$89
LivaNova USA, Inc.
$72
SCILEX PHARMACEUTICALS INC.
$69
Genentech, Inc.
$55
Neurelis, Inc.
$55
Banner Life Sciences, LLC
$48
GE HEALTHCARE
$41
Scilex Pharmaceuticals Inc.
$38
ARBOR PHARMACEUTICALS, INC.
$37
Kyowa Kirin, Inc.
$37
Sandoz Inc.
$31
Merz Pharmaceuticals, LLC
$26
EISAI INC.
$24
BANNER LIFE SCIENCES, LLC
$24
Averitas Pharma Inc.
$24
IMPEL PHARMACEUTICALS INC.
$23
Vanda Pharmaceuticals Inc.
$21
Cala Health, Inc.
$21
Xeris Pharmaceuticals, Inc.
$20
Merck Sharp & Dohme LLC
$19
Allergan, Inc.
$16
Currax Pharmaceuticals LLC
$15
MDD US Operations, LLC
$14
Arbor Pharmaceuticals, Inc.
$13
Top 3 companies account for 26.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AFINITOR · AIMOVIG · AJOVY · AMVUTTRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aduhelm · Aimovig · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BRIUMVI · Briviact · CALA TRIO · CONTRAVE · CREXONT · DUOPA · EMGALITY · EPIDIOLEX · Enspryng · FIRDAPSE · FYCOMPA · Fabhalta · Fycompa · GILENYA · GVOKE PFS · Gamunex-C · HYQVIA · Hizentra · Horizant · IN.PACT ADMIRAL · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LEQEMBI · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NEXVIAZYME · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · Ocrevus · Ongentys · PANZYGA · PONVORY · QULIPTA · QUTENZA · RADICAVA · REXULTI · RYTARY · Rystiggo · SKYCLARYS · SOLIRIS · Soliris · TECFIDERA · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · XYWAV · Xeomin · ZEPOSIA · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a gerontology nurse practitioner in Altamonte Springs?
Compare gerontology nurse practitioners in the Altamonte Springs area by procedure volume, costs, and industry payment transparency.
Browse gerontology nurse practitioners nearby

Geographic Context

Gerontology nurse practitioners in nearby ZIP areas
119
County median income
$83,030
Nearest hospital to ZIP centroid (approximate)
ASPIRE HEALTH PARTNERS
6.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Gimon is a gerontology nurse practitioner.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Gimon receive payments from pharmaceutical companies?
Yes. Gimon received a total of $16,558 from 65 companies across 657 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Gimon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →